#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Hairy cell leukaemia Atypical haemolytic uraemic syndrome B precursor type acute leukaemia Plasma cell myeloma recurrent Blood iron increased Congenital ectodermal dysplasia Selective polysaccharide antibody deficiency Skin angiosarcoma Guillain-Barre syndrome Ehlers-Danlos syndrome Bronchopulmonary aspergillosis Necrotising enterocolitis neonatal Ewing's sarcoma metastatic Myeloproliferative neoplasm More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Life with Disease VEXAS syndrome Leiomyosarcoma recurrent – Diagnostics Retinoblastoma – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Mantle cell lymphoma stage II – Life with Disease Chordoma – Basic Information Gastrointestinal stromal tumour Sjogren’s syndrome Osteosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Acetate Ozanimod Hydrochloride Cetrelimab Glpg3667 Fumarate Thalidomide Carbamazepine Nitric Oxide Tapentadol Hydrochloride METHYLPHENIDATE Acetylsalicylic Acid Isoleucine Arbaclofen Brivaracetam TRONTINEMAB Sodium Butyrate Livmoniplimab Dapagliflozin Erythromycin Purified Egg Phospholipids Anakinra More therapies…

    Learn about Your Condition

    COVID-19 Amyotrophic lateral sclerosis Myotonic dystrophy Thrombosis Diabetic nephropathy Neck pain Hypertonic bladder Epileptic encephalopathy Hysterectomy Atopic keratoconjunctivitis Plasma cell myeloma recurrent Nephrogenic anaemia Lichen planopilaris Adenovirus infection Hypertrophic cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on Metformin and Colchicine for Patients with Long COVID Symptoms

    Recruiting

    3 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Metformin
    • Minocycline
    • Colchicine
    The Netherlands

  • Study Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dolutegravir
    • Doravirine
    • Lamivudine
    France

  • Study of IM-250 capsules compared to placebo in patients with recurrent genital herpes

    Recruiting

    1 1
    Investigated Diseases:
    • Genital herpes simplex
    Investigated Drugs:
    • (S)-2-(2′,5′-DIFLUORO-[1,1′-BIPHENYL]-4-YL)-N-METHYL-N-(4-METHYL-5-(S-METHYLSULFONIMIDOYL)THIAZOL-2-YL)ACETAMIDE
    Bulgaria Estonia

  • Study on the Effectiveness of 10-1074-LS and Teropavimab in Controlling HIV in Patients with Early Stage HIV Infection

    Recruiting

    2 1 1
    Investigated Drugs:
    • 10-1074-Ls
    • Teropavimab
    • Sodium Chloride
    Belgium Denmark Germany The Netherlands Spain Sweden

  • Study on Anticoagulation Strategies with Heparin, Enoxaparin, and Argatroban for Patients with Respiratory or Circulatory Failure on ECMO Support

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    • Acute respiratory failure
    • Respiratory failure
    Investigated Drugs:
    • Argatroban Monohydrate
    • Heparin Sodium
    • Enoxaparin Sodium
    Austria

  • Study on Preventing Respiratory Infections and Wheezing in Late-Moderate Preterm Infants Using Bacterial Lysates

    Recruiting

    3 1 1 1
    The Netherlands
Previous Page
1 … 7 8 9 10 11 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!